413 related articles for article (PubMed ID: 32942999)
1. Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study.
Yebyo HG; Zappacosta S; Aschmann HE; Haile SR; Puhan MA
BMC Cardiovasc Disord; 2020 Sep; 20(1):418. PubMed ID: 32942999
[TBL] [Abstract][Full Text] [Related]
2. Finding the Balance Between Benefits and Harms When Using Statins for Primary Prevention of Cardiovascular Disease: A Modeling Study.
Yebyo HG; Aschmann HE; Puhan MA
Ann Intern Med; 2019 Jan; 170(1):1-10. PubMed ID: 30508425
[TBL] [Abstract][Full Text] [Related]
3. Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contexts.
Yebyo HG; Aschmann HE; Yu T; Puhan MA
BMC Cardiovasc Disord; 2018 May; 18(1):97. PubMed ID: 29776337
[TBL] [Abstract][Full Text] [Related]
4. Net benefit of statins for primary prevention of cardiovascular disease in people 75 years or older: a benefit-harm balance modeling study.
Yebyo HG; Aschmann HE; Menges D; Boyd CM; Puhan MA
Ther Adv Chronic Dis; 2019; 10():2040622319877745. PubMed ID: 31598209
[TBL] [Abstract][Full Text] [Related]
5. Time to improve statin prescription guidelines in low-risk patients?
Balder JW; de Vries JK; Mulder DJ; Kamphuisen PW
Eur J Prev Cardiol; 2017 Jul; 24(10):1064-1070. PubMed ID: 28429651
[TBL] [Abstract][Full Text] [Related]
6. The implications of competing risks and direct treatment disutility in cardiovascular disease and osteoporotic fracture: risk prediction and cost effectiveness analysis.
Guthrie B; Rogers G; Livingstone S; Morales DR; Donnan P; Davis S; Youn JH; Hainsworth R; Thompson A; Payne K
Health Soc Care Deliv Res; 2024 Feb; 12(4):1-275. PubMed ID: 38420962
[TBL] [Abstract][Full Text] [Related]
7. Adherence to statins and its impact on clinical outcomes: a retrospective population-based study in China.
Zhao B; He X; Wu J; Yan S
BMC Cardiovasc Disord; 2020 Jun; 20(1):282. PubMed ID: 32522146
[TBL] [Abstract][Full Text] [Related]
8. The impact of statin discontinuation and restarting rates on the optimal time to initiate statins and on the number of cardiovascular events prevented.
Pate A; Elliott RA; Gkountouras G; Thompson A; Emsley R; van Staa T
Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):644-652. PubMed ID: 32394495
[TBL] [Abstract][Full Text] [Related]
9. Time trends in statin use and incidence of recurrent cardiovascular events in secondary prevention between 1999 and 2013: a registry-based study.
Laleman N; Henrard S; van den Akker M; Goderis G; Buntinx F; Van Pottelbergh G; Vaes B
BMC Cardiovasc Disord; 2018 Nov; 18(1):209. PubMed ID: 30400778
[TBL] [Abstract][Full Text] [Related]
10. Sex Differences in the Use of Statins in Community Practice.
Nanna MG; Wang TY; Xiang Q; Goldberg AC; Robinson JG; Roger VL; Virani SS; Wilson PWF; Louie MJ; Koren A; Li Z; Peterson ED; Navar AM
Circ Cardiovasc Qual Outcomes; 2019 Aug; 12(8):e005562. PubMed ID: 31416347
[TBL] [Abstract][Full Text] [Related]
11. Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry.
Nanna MG; Navar AM; Wang TY; Mi X; Virani SS; Louie MJ; Lee LV; Goldberg AC; Roger VL; Robinson J; Peterson ED
J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29739801
[TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participants.
Yebyo HG; Aschmann HE; Kaufmann M; Puhan MA
Am Heart J; 2019 Apr; 210():18-28. PubMed ID: 30716508
[TBL] [Abstract][Full Text] [Related]
13. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement.
; Mangione CM; Barry MJ; Nicholson WK; Cabana M; Chelmow D; Coker TR; Davis EM; Donahue KE; Jaén CR; Kubik M; Li L; Ogedegbe G; Pbert L; Ruiz JM; Stevermer J; Wong JB
JAMA; 2022 Aug; 328(8):746-753. PubMed ID: 35997723
[TBL] [Abstract][Full Text] [Related]
14. The efficiency of cardiovascular risk assessment: do the right patients get statin treatment?
van Staa TP; Smeeth L; Ng ES; Goldacre B; Gulliford M
Heart; 2013 Nov; 99(21):1597-602. PubMed ID: 23735939
[TBL] [Abstract][Full Text] [Related]
15. Comparing Guidelines for Statin Treatment in Canada and the United States.
Hennessy DA; Bushnik T; Manuel DG; Anderson TJ
J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26175357
[TBL] [Abstract][Full Text] [Related]
16. A systematic review and economic evaluation of statins for the prevention of coronary events.
Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
[TBL] [Abstract][Full Text] [Related]
17. Use of statins for the prevention of cardiovascular disease in 41 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data.
Marcus ME; Manne-Goehler J; Theilmann M; Farzadfar F; Moghaddam SS; Keykhaei M; Hajebi A; Tschida S; Lemp JM; Aryal KK; Dunn M; Houehanou C; Bahendeka S; Rohloff P; Atun R; Bärnighausen TW; Geldsetzer P; Ramirez-Zea M; Chopra V; Heisler M; Davies JI; Huffman MD; Vollmer S; Flood D
Lancet Glob Health; 2022 Mar; 10(3):e369-e379. PubMed ID: 35180420
[TBL] [Abstract][Full Text] [Related]
18. Statins in the primary and secondary prevention of cardiovascular disease in women: facts and myths.
Virani SS
Tex Heart Inst J; 2013; 40(3):288-9. PubMed ID: 23914021
[No Abstract] [Full Text] [Related]
19. Increases in statin eligibility to reduce cardiovascular risk according to the 2013 ACC/AHA cholesterol guidelines in the Africa Middle East region: a sub-analysis of the Africa Middle East Cardiovascular Epidemiological (ACE) study.
Hamoui O; Omar MI; Raal FJ; Rashed W; Kane A; Alami M; Abreu P; Mashhoud W; Alsheikh-Ali AA
BMC Cardiovasc Disord; 2019 Mar; 19(1):61. PubMed ID: 30876390
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort.
Bai JW; Boulet G; Halpern EM; Lovblom LE; Eldelekli D; Keenan HA; Brent M; Paul N; Bril V; Cherney DZ; Weisman A; Perkins BA
Cardiovasc Diabetol; 2016 Jan; 15():14. PubMed ID: 26809442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
